Search Results
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria
Search for other papers by Francesca Ruggieri in
Google Scholar
PubMed
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria
Search for other papers by Katharina Jonas in
Google Scholar
PubMed
Search for other papers by Manuela Ferracin in
Google Scholar
PubMed
Search for other papers by Michael Dengler in
Google Scholar
PubMed
Search for other papers by Vanessa Jӓger in
Google Scholar
PubMed
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria
Department of Hematology and Oncology, Medical Faculty, University of Augsburg, Augsburg, Germany
Translational Oncology, University Hospital of Augsburg, Augsburg, Germany
Search for other papers by Martin Pichler in
Google Scholar
PubMed
molecular mechanisms ( Fig. 3 ). This regulation depends on cell type, physiological conditions, and external factors. miRNAs are mainly transcribed by RNA polymerase II from intergenic, intronic, or polycistronic loci to long primary transcripts, called pri